Literature DB >> 20367448

Sodium channels in normal and pathological pain.

Sulayman D Dib-Hajj1, Theodore R Cummins, Joel A Black, Stephen G Waxman.   

Abstract

Nociception is essential for survival whereas pathological pain is maladaptive and often unresponsive to pharmacotherapy. Voltage-gated sodium channels, Na(v)1.1-Na(v)1.9, are essential for generation and conduction of electrical impulses in excitable cells. Human and animal studies have identified several channels as pivotal for signal transmission along the pain axis, including Na(v)1.3, Na(v)1.7, Na(v)1.8, and Na(v)1.9, with the latter three preferentially expressed in peripheral sensory neurons and Na(v)1.3 being upregulated along pain-signaling pathways after nervous system injuries. Na(v)1.7 is of special interest because it has been linked to a spectrum of inherited human pain disorders. Here we review the contribution of these sodium channel isoforms to pain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20367448     DOI: 10.1146/annurev-neuro-060909-153234

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN: 0147-006X            Impact factor:   12.449


  240 in total

Review 1.  Targeting voltage-gated sodium channels for treatment for chronic visceral pain.

Authors:  Fei-Hu Qi; You-Lang Zhou; Guang-Yin Xu
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

2.  17β-Estradiol regulates the gene expression of voltage-gated sodium channels: role of estrogen receptor α and estrogen receptor β.

Authors:  Fang Hu; Qiang Wang; Peizhi Wang; Wenjuan Wang; Wenyi Qian; Hang Xiao; Lin Wang
Journal:  Endocrine       Date:  2011-12-15       Impact factor: 3.633

3.  Differential expression of sodium channel β subunits in dorsal root ganglion sensory neurons.

Authors:  Cojen Ho; Juan Zhao; Steven Malinowski; Mohamed Chahine; Michael E O'Leary
Journal:  J Biol Chem       Date:  2012-03-09       Impact factor: 5.157

4.  A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia.

Authors:  Gilberto Vargas-Alarcon; Edith Alvarez-Leon; Jose-Manuel Fragoso; Angelica Vargas; Aline Martinez; Maite Vallejo; Manuel Martinez-Lavin
Journal:  BMC Musculoskelet Disord       Date:  2012-02-20       Impact factor: 2.362

5.  Extending the clinical spectrum of pain channelopathies.

Authors:  Henry Houlden
Journal:  Brain       Date:  2012-02       Impact factor: 13.501

6.  Alterations of gene expression of sodium channels in dorsal root ganglion neurons of estrogen receptor knockout (ERKO) mice induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Authors:  Haixia Ding; Qiang Wang; Jingli Liu; Wenyi Qian; Wenjuan Wang; Jun Wang; Rong Gao; Hang Xiao
Journal:  Endocrine       Date:  2012-02-28       Impact factor: 3.633

7.  Selective silencing of Na(V)1.7 decreases excitability and conduction in vagal sensory neurons.

Authors:  Yukiko Muroi; Fei Ru; Marian Kollarik; Brendan J Canning; Stephen A Hughes; Stacey Walsh; Martin Sigg; Michael J Carr; Bradley J Undem
Journal:  J Physiol       Date:  2011-10-17       Impact factor: 5.182

Review 8.  Pain disorders and erythromelalgia caused by voltage-gated sodium channel mutations.

Authors:  Ron Dabby
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

Review 9.  Neurological channelopathies: new insights into disease mechanisms and ion channel function.

Authors:  Dimitri M Kullmann; Stephen G Waxman
Journal:  J Physiol       Date:  2010-04-07       Impact factor: 5.182

Review 10.  The discovery and development of analgesics: new mechanisms, new modalities.

Authors:  Gillian Burgess; Dic Williams
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.